全文获取类型
收费全文 | 5621篇 |
免费 | 342篇 |
国内免费 | 63篇 |
专业分类
耳鼻咽喉 | 44篇 |
儿科学 | 185篇 |
妇产科学 | 104篇 |
基础医学 | 757篇 |
口腔科学 | 48篇 |
临床医学 | 575篇 |
内科学 | 1354篇 |
皮肤病学 | 94篇 |
神经病学 | 417篇 |
特种医学 | 460篇 |
外国民族医学 | 3篇 |
外科学 | 525篇 |
综合类 | 47篇 |
一般理论 | 2篇 |
预防医学 | 548篇 |
眼科学 | 27篇 |
药学 | 528篇 |
中国医学 | 4篇 |
肿瘤学 | 304篇 |
出版年
2023年 | 22篇 |
2022年 | 42篇 |
2021年 | 82篇 |
2020年 | 50篇 |
2019年 | 95篇 |
2018年 | 124篇 |
2017年 | 104篇 |
2016年 | 118篇 |
2015年 | 119篇 |
2014年 | 151篇 |
2013年 | 216篇 |
2012年 | 281篇 |
2011年 | 265篇 |
2010年 | 158篇 |
2009年 | 195篇 |
2008年 | 255篇 |
2007年 | 290篇 |
2006年 | 240篇 |
2005年 | 240篇 |
2004年 | 220篇 |
2003年 | 183篇 |
2002年 | 181篇 |
2001年 | 154篇 |
2000年 | 156篇 |
1999年 | 107篇 |
1998年 | 115篇 |
1997年 | 115篇 |
1996年 | 137篇 |
1995年 | 97篇 |
1994年 | 97篇 |
1993年 | 81篇 |
1992年 | 110篇 |
1991年 | 90篇 |
1990年 | 91篇 |
1989年 | 128篇 |
1988年 | 108篇 |
1987年 | 89篇 |
1986年 | 90篇 |
1985年 | 92篇 |
1984年 | 44篇 |
1983年 | 44篇 |
1982年 | 35篇 |
1981年 | 28篇 |
1980年 | 22篇 |
1979年 | 24篇 |
1978年 | 40篇 |
1977年 | 20篇 |
1976年 | 33篇 |
1975年 | 37篇 |
1974年 | 22篇 |
排序方式: 共有6026条查询结果,搜索用时 15 毫秒
1.
2.
3.
Five 3'-fluorinated ribonucleosides were prepared and evaluated for their inhibitory properties against different viruses. The synthesis of these compounds was achieved by treatment of 2',5'-di-O-tritylated nucleoside analogues possessing a xylo-configuration with diethylaminosulfur trifluoride, followed by deprotection. 3'-Fluoro-3'-deoxyadenosine was active against a broad range of viruses, encompassing both DNA viruses [pox (vaccinia)], single-stranded (+) RNA viruses [picorna (polio, Coxsackie B), toga (sindbis, Semliki Forest)] and double-stranded RNA viruses (reo). In its antiviral activity spectrum 3'-fluoro-3'-deoxyadenosine clearly differed from those adenosine analogues that are known as inhibitors of S-adenosylhomocysteine hydrolase. 3'-Fluoro-3'-deoxyadenosine also proved effective in vivo, in inhibiting tail lesion formation in mice inoculated intravenously with vaccinia virus. 相似文献
4.
5.
6.
7.
Leonidas JC; Berdon WE; Valderrama E; Neveling U; Schuval S; Weiss SJ; Hilfer C; Godine L 《Radiology》1996,198(2):377
8.
9.
10.
JC Sitek† M Loeb‡ JR Ronnevig¶ 《Journal of the European Academy of Dermatology and Venereology》2007,21(7):891-896
BACKGROUND: Since 1997, a number of trials have shown promising results in treating generalized vitiligo with narrowband ultraviolet B (UVB) both in adults and children. However, there is little knowledge concerning the duration and permanency of the treatment-induced repigmentation. OBJECTIVE: Our main objective was to perform a follow-up trial of successfully treated patients receiving narrowband UVB for generalized vitiligo. METHODS: We have investigated to what degree the treatment-induced repigmentation remains stable for up to 2 years post-treatment. We performed an initial open trial including 31 patients with generalized vitiligo. They received narrowband UVB thrice weekly for up to 12 months. Patients experiencing > 75% repigmentation were defined responders and were included in the follow-up trial. Responders were followed every 6 months for up to 2 years after cessation of treatment. We observed the pigmentation status and registered any changes indicating loss of pigmentation and relapse. RESULTS: Eleven of the 31 treated patients were included in the follow-up trial. Six patients had relapse and five patients had stable response 24 months after cessation of treatment. Four out of six relapses were within 6 months post-treatment. CONCLUSION: In our study population of 31 patients with generalized vitiligo, five patients (16%) experienced > 75% stable repigmentation 2 years after cessation of a treatment programme of up to 1 years narrowband UVB therapy. 相似文献